Does Liquorice Root, Hawthorn Fruit and Chinese Plum Tea Improve Quality of Life in Head and Neck Cancer Patients after Primary or Adjuvant Radiotherapy? – A Randomized Double-blind Pilot Study

Ulana Kotowski ( Medical University of Vienna )

Muhammad Faisal ( Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )

Yan Ma ( Medical University Vienna )

Inamaria Erovic ( Landesklinikum Baden-Mödling, Baden, Austria )

Boban M. Erovic ( Evangelical Hospital Vienna, Vienna, Austria )

https://doi.org/10.37155/2717-5278-0301-2

Abstract

Objectives:Radiation induced side effects in head and neck cancers have life changing impact after treatment. We conducted a study to evaluate the effectiveness of traditional Chinese medicine tea in these patients. Methods: A randomized double-blinded pilot study was performed in head and neck cancer patients treated with radiotherapy. The study group received gargles of tea made from liquorice root, hawthorn fruit and Chinese plum. The quality of life was evaluated using the University of Washington Quality of life questionnaire Version 4 (UW-QOL). Results:The intervention group showed marginally significant outcome (p=0.075) in improved saliva production and reduced anxiety. Bitter taste was one of the major reasons for not continuing the trial. Conclusions:The proposed tea seems to provide a promising impact on the quality of life in head and neck cancer patients after adjuvant or primary radiotherapy. However, taste is a major concern and has to be adjusted to reduce patients´ dropout rate. Future trial with large samples are required to declare significant benefits.

Keywords

Head and neck neoplasms; Quality of life; Traditional Chinese medicine; Radiotherapy

Full Text

PDF

References

[1].Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
[2].Swift AC. Principles and Practice of Head and Neck Oncology. 2003.
[3].Jones E, Lund VJ, Howard DJ, Greenberg MP, McCarthy M. Quality of life of patients treated surgically for head and neck cancer. J Laryngol Otol. 1992;106:238–42.
[4].Rogers SN, Hannah L, Lowe D, Magennis P. Quality of life 5-10 years after primary surgery for oral and oro-pharyngeal cancer. J Craniomaxillofac Surg. 1999;27:187–91.
[5].Chan ATC, Grégoire V, Lefebvre J-L, Licitra L, Hui EP, Leung SF, et al. Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2012. pp. vii83–5.
[6].Grégoire V, Lefebvre J-L, Licitra L, Felip E, EHNS–ESMO–ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2010. pp. v184–6.
[7].Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag. Dove Press; 2015;11:171–88.
[8].Molassiotis A, Ozden G, Platin N, Scott JA, Pud D, Fernandez-Ortega P, et al. Complementary and alternative medicine use in patients with head and neck cancers in Europe. Eur J Cancer Care (Engl). John Wiley & Sons, Ltd; 2006;15:19–24.
[9].Laverick S, Lowe D, Brown JS, Vaughan ED, Rogers SN. The impact of neck dissection on health-related quality of life. Arch. Otolaryngol. Head Neck Surg. American Medical Association; 2004;130:149–54.
[10].Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med. John Wiley & Sons, Ltd; 2019;8:1958–75.
[11].Liu T-G, Xiong S-Q, Yan Y, Zhu H, Yi C. Use of chinese herb medicine in cancer patients: a survey in southwestern china. Evid Based Complement Alternat Med. Hindawi; 2012;2012:769042.
[12].Lin H-C, Lin C-L, Huang W-Y, Shangkuan W-C, Kang B-H, Chu Y-H, et al. The use of adjunctive traditional Chinese medicine therapy and survival outcome in patients with head and neck cancer: a nationwide population-based cohort study. QJM. 2015;108:959–65.
[13].Chen S, Flower A, Ritchie A, Liu J, Molassiotis A, Yu H, et al. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review. Lung Cancer. 2010;68:137–45.
[14].Nie J, Zhao C, Deng LI, Chen J, Yu B, Wu X, et al. Efficacy of traditional Chinese medicine in treating cancer. Biomed Rep. Spandidos Publications; 2016;4:3–14.
[15].Carmady B, Smith CA. Use of Chinese medicine by cancer patients: a review of surveys. Chin Med. BioMed Central; 2011;6:22–8.
[16].Kazi R, De Cordova J, Kanagalingam J, Venkitaraman R, Nutting CM, Clarke P, et al. Quality of life following total laryngectomy: assessment using the UW-QOL scale. ORL J. Otorhinolaryngol. Relat. Spec. 2007;69:100–6.
[17].Weymuller EA, Alsarraf R, Yueh B, Deleyiannis FW, Coltrera MD. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch. Otolaryngol. Head Neck Surg. American Medical Association; 2001;127:489–93.
[18].Gupta VK, Fatima A, Faridi U, Negi AS, Shanker K, Kumar JK, et al. Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharmacol. 2008;116:377–80.
[19].Jo E-H, Hong H-D, Ahn N-C, Jung J-W, Yang S-R, Park J-S, et al. Modulations of the Bcl-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell. J. Agric. Food Chem. 2004;52:1715–9.
[20].Kuriyama A, Maeda H. Topical application of licorice for prevention of postoperative sore throat in adults: A systematic review and meta-analysis. J Clin Anesth. 2019;54:25–32.
[21].Najafi S, Koujan SE, Manifar S, Kharazifard MJ, Kidi S, Hajheidary S. Preventive Effect of Glycyrrhiza Glabra Extract on Oral Mucositis in Patients Under Head and Neck Radiotherapy: A Randomized Clinical Trial. J Dent (Tehran). Tehran University of Medical Sciences; 2017;14:267–74.
[22].Chu S-M, Shih W-T, Yang Y-H, Chen P-C, Chu Y-H. Use of traditional Chinese medicine in patients with hyperlipidemia: A population-based study in Taiwan. J Ethnopharmacol. 2015;168:129–35.
[23].Tadić VM, Dobrić S, Marković GM, Dordević SM, Arsić IA, Menković NR, et al. Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. J. Agric. Food Chem. 2008;56:7700–9.
[24].Li T, Zhu J, Guo L, Shi X, Liu Y, Yang X. Differential effects of polyphenols-enriched extracts from hawthorn fruit peels and fleshes on cell cycle and apoptosis in human MCF-7 breast carcinoma cells. Food Chem. 2013;141:1008–18.
[25].Bailly C. Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot). J Ethnopharmacol. Elsevier; 2020;246:112215.
[26].Jin H-L, Lee B-R, Lim K-J, Debnath T, Shin H-M, Lim B-O. Anti-Inflammatory Effects of Prunus mume Mixture in Colitis Induced by Dextran Sodium Sulfate. Korean Journal of Medicinal Crop Science. The Korean Society of Medicinal Crop Science; 2011;19:16–23.
[27].Enomoto S, Yanaoka K, Utsunomiya H, Niwa T, Inada K, Deguchi H, et al. Inhibitory effects of Japanese apricot (Prunus mume Siebold et Zucc.; Ume) on Helicobacter pylori-related chronic gastritis. Eur J Clin Nutr. Nature Publishing Group; 2010;64:714–9.
[28].Ying Joanna ND, Thomson WM. Dry mouth - An overview. Singapore Dent J. 2015;36:12–7.
Chandrashekar J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, et al. T2Rs function as bitter taste receptors. Cell. 2000;100:703–11.

Copyright © 2021 Ulana Kotowski, Muhammad Faisal, Yan Ma, Inamaria Erovic, Boban M. Erovic Creative Commons License Publishing time:2022-06-30
This work is licensed under a Creative Commons Attribution 4.0 International License